Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.

Amann F, Hefner G, Cremer-Schaeffer P, Gründer G, Häuser W, Hart XM, Petzke F, Zernig G, Havemann-Reinecke U

Open source

DOI
10.1055/a-2853-4984
Published
2026 Jun 10
Container
Pharmacopsychiatry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-2853-4984,
  title = {Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.},
  author = {Amann F and Hefner G and Cremer-Schaeffer P and Gründer G and Häuser W and Hart XM and Petzke F and Zernig G and Havemann-Reinecke U},
  year = {2026},
  journal = {Pharmacopsychiatry},
  doi = {10.1055/a-2853-4984},
  url = {https://doi.org/10.1055/a-2853-4984}
}

RIS

TY  - JOUR
TI  - Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.
AU  - Amann F
AU  - Hefner G
AU  - Cremer-Schaeffer P
AU  - Gründer G
AU  - Häuser W
AU  - Hart XM
AU  - Petzke F
AU  - Zernig G
AU  - Havemann-Reinecke U
PY  - 2026
JO  - Pharmacopsychiatry
DO  - 10.1055/a-2853-4984
UR  - https://doi.org/10.1055/a-2853-4984
ER  - 

APA

F, A., G, H., P, C., G, G., W, H., XM, H., F, P., G, Z., & U, H. (2026). Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.. Pharmacopsychiatry. https://doi.org/10.1055/a-2853-4984

Source records